Company intelligence / Profile preview

TBD Pharmatech

Tartu, Tartu County, Estoniatbdpharmatech.com ↗

Ownership: Private
Employees: ~50
Development stage: Commercial

Overview

TBD Pharmatech is an established EU-based CDMO specializing in the development and GMP-compliant manufacturing of small-molecule active pharmaceutical ingredients (APIs) and fine chemicals. The company supports global pharma/biotech clients from early-stage development through to commercial supply. It operates two GMP-certified facilities in Estonia with ISO 9001 certification since 2008. Its product portfolio includes over 30 APIs/fine chemicals, including generics like bortezomib, butorphanol tartrate, and pomalidomide. Revenue for FY2022 was €5.17 million[6], with ongoing expansion into new facilities to increase capacity[1][2][4][6].

Modalities: Small moleculeSynthetic small moleculeFine chemical
Industry: Contract Manufacturing Organization

Beyond the preview

Go deeper on TBD Pharmatech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on TBD Pharmatech.

Explore the full profile